IL17A and tuberculosis: In evaluating CD4+RORγT+IL-17+, we observed an increase in the percentage of antigen-specific cells in TB-treated patients compared with the active-TB patients and TST+ controls (P < 0.0001 and P < 0.0001, resp., Kruskal-Wallis test followed by Dunn's post hoc test).